Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial

BACKGROUND: Approximately 20 % of hepatocellular carcinoma (HCC) patients diagnosed in the early stages may benefit from potentially curative ablative therapies such as surgical resection, transplantation or radiofrequency ablation. For patients not eligible for such options, prognosis is poor. Sora...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Gandhi, Mihir, Choo, Su Pin, Thng, Choon Hua, Tan, Say Beng, Low, Albert Su Chong, Cheow, Peng Chung, Goh, Anthony Soon Whatt, Tay, Kiang Hiong, Lo, Richard Hoau Gong, Goh, Brian Kim Poh, Wong, Jen San, Ng, David Chee Eng, Soo, Khee Chee, Liew, Wei Ming, Chow, Pierce K. H.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5100089/
https://ncbi.nlm.nih.gov/pubmed/27821083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2868-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares